chr6-137145740-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_052962.3(IL22RA2):c.676G>T(p.Val226Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000479 in 1,461,660 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_052962.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
IL22RA2 | NM_052962.3 | c.676G>T | p.Val226Phe | missense_variant | 7/7 | ENST00000296980.7 | |
IL22RA2 | NM_181309.2 | c.580G>T | p.Val194Phe | missense_variant | 6/6 | ||
IL22RA2 | NM_181310.2 | c.*17G>T | 3_prime_UTR_variant | 5/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
IL22RA2 | ENST00000296980.7 | c.676G>T | p.Val226Phe | missense_variant | 7/7 | 1 | NM_052962.3 | ||
IL22RA2 | ENST00000349184.9 | c.580G>T | p.Val194Phe | missense_variant | 6/6 | 1 | P1 | ||
IL22RA2 | ENST00000339602.3 | c.*17G>T | 3_prime_UTR_variant | 5/5 | 1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000279 AC: 7AN: 250962Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135614
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1461660Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 727124
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 21, 2023 | The c.676G>T (p.V226F) alteration is located in exon 7 (coding exon 6) of the IL22RA2 gene. This alteration results from a G to T substitution at nucleotide position 676, causing the valine (V) at amino acid position 226 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at